Cancer Vaccine

Cancer Vaccine

If caught early, the skin cancer called malignant melanoma is curable. If not, it's almost always fatal. But a new treatment under study at the John Wayne Cancer Institute in Santa Monica, Calif., appears at least to prolong lives. Researchers injected patients with a tuberculosis vaccine mixed with melanoma cells. Result: average survival went from seven to 23 months, with some staying cancer free for eight years. The doctors warn that an approved vaccine could take a decade.


Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!